What is FIGS?
FIGS operates as a founder-led, direct-to-consumer healthcare apparel and lifestyle brand, fundamentally disrupting the traditional medical uniform market. By integrating technically advanced fabrics with a focus on comfort, durability, and aesthetic appeal, the company has established a unique value proposition for healthcare professionals. Its digital-first distribution model allows for a seamless, high-touch customer experience, positioning FIGS as a critical infrastructure provider for the modern medical workforce. The company's market position is defined by its ability to blend functional utility with lifestyle branding, effectively capturing a loyal demographic that prioritizes both performance and professional identity.
How much funding has FIGS raised?
FIGS has raised a total of $652M across 4 funding rounds:
Unspecified
$2M
Series A
$5M
Private Equity
$65M
Share Placement
$580M
Unspecified (2013): $2M with participation from 500.com, Karlin Ventures, Mohr Davidow Ventures, and Crocs
Series A (2016): $5M led by Campfire Capital
Private Equity (2018): $65M supported by Tulco
Share Placement (2021): $580M, investors not publicly disclosed
Key Investors in FIGS
500.com
500.com Limited is a leading online service provider that offers integrated suites of digital tools and community venues, bringing significant expertise in online platform management.
Karlin Ventures
Karlin Ventures is a high-tech real estate and investment firm that specializes in creating innovative environments for leading-edge brands across the life science and technology sectors.
Campfire Capital
Campfire Capital is a specialized investment fund comprised of retail industry experts who provide strategic guidance and capital to high-growth consumer brands.
What's next for FIGS?
Following this major strategic investment, FIGS is well-positioned to accelerate its operational expansion and deepen its market penetration. The company is expected to leverage this capital to enhance its supply chain resilience, invest in product innovation, and potentially explore new categories within the healthcare lifestyle ecosystem. As the firm transitions into its next phase of maturity, the focus will likely shift toward sustaining high-margin growth while defending its market share against emerging competitors. By maintaining its direct-to-consumer advantage, FIGS remains poised to capitalize on the increasing demand for premium, purpose-built apparel in the healthcare sector.
See full FIGS company page
